Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hims & Hers Health Inc.

28.40
+2.419.27%
Volume:20.22M
Turnover:550.51M
Market Cap:6.31B
PE:53.36
High:29.65
Open:24.49
Low:23.98
Close:25.99
Loading ...

Hims & Hers Health Stock Drops After Q4 Report: EPS In-Line, Revenues Beat

Benzinga
·
25 Feb

Hims & Hers Health Q4 2024 GAAP EPS $0.11, Inline, Sales $481.14M Beat $470.31M Estimate

Benzinga
·
25 Feb

Hims & Hers Health Drops 14.3% in Extended Trading After Posting Quarterly Results

THOMSON REUTERS
·
25 Feb

Hims & Hers Health Guides For Q1 Revenue of $520-$540 Million, vs FactSet Analyst Consensus of $497 Million

MT Newswires Live
·
25 Feb

BRIEF-Hims & Hers Health Q4 Revenue USD 481.1 Million Vs. IBES Estimate USD 470.3 Million

Reuters
·
25 Feb

Hims & Hers Health Q4 Gross Margin 77%

THOMSON REUTERS
·
25 Feb

Hims & Hers Health Inc Q1 REV View $497.0 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
25 Feb

Hims & Hers Health Inc - Expects Q1 2025 Revenue of $520-$540 Million

THOMSON REUTERS
·
25 Feb

Hims & Hers Health Inc FY2025 REV View $2.09 Bln -- Lseg Ibes Data

THOMSON REUTERS
·
25 Feb

Hims & Hers Health Inc - Expects 2025 Revenue of $2.3-$2.4 Billion

THOMSON REUTERS
·
25 Feb

Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

Business Wire
·
25 Feb

U.S. Stocks to Watch: Berkshire Hathaway, Alibaba, Nvidia, Domino's Pizza, and More

Dow Jones
·
24 Feb

Hims & Hers Health (NYSE:HIMS) Climbs 60% Despite Market Volatility

Simply Wall St.
·
24 Feb

1 Stock to Buy, 1 Stock to Sell This Week: Nvidia, Lowe’s

Investing.com
·
23 Feb

Elon Musk's DOGE overdrive, Trump bashes Boeing, and supersonic planes: Business news roundup

Quartz
·
22 Feb

Post-Bell|S&P 500, Nasdaq End Down Nearly 2%; UnitedHealth Declines 7%; Coinbase Sinks 8%; Block Falls 18%; Celsius Holdings Soars 28%

Tiger Newspress
·
22 Feb

FDA says Ozempic and Wegovy shortage is ending. That's bad news for this wellness stock.

Dow Jones
·
22 Feb

Novo Nordisk Shares Rise After FDA Clears Shortage of Anti-Obesity Drugs -- WSJ

Dow Jones
·
22 Feb

Hims & Hers Stock Plummets. The Wegovy Shortage Is Over. -- Barrons.com

Dow Jones
·
22 Feb

Hims & Hers Health (NYSE:HIMS) Stock Surges 162% Despite Broader Market Declines

Simply Wall St.
·
22 Feb